About Larry Kauvar
Larry Kauvar, Ph.D., is chief science officer and founder of Trellis Bioscience in Redwood City, California. Trellis is developing human antibody drugs against bacterial biofilms. Its lead drug, calpurbatug (TRL1068), is being paired with antibiotics to treat prosthetic joint infections.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Larry Kauvar in the role, so the role may have started earlier or lasted longer.
Trellis Bioscience, Inc. Current
CSO and Founder
2009 – Present · Redwood City, CA
Clinical-stage antibody drug developer targeting the bacterial biofilms that shield chronic infections from antibiotics, starting with prosthetic joint infections.
Key Colleagues at Startups
The people Larry Kauvar works with at each company, as listed on that company's latest Form D.
Trellis Bioscience, Inc. · Form D/A, Oct 29, 2026
NM
Nora Mende
CFO